Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escalating Dose IV MTX vs Oral MTX in Standard Risk ALL (CCG-1991)
NCT00005945Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Jun 2000
- Primary completion
- Nov 2007
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of methotrexate in acute lymphoblastic leukemia (ALL), sponsored by Children's Oncology Group. Started Jun 2000; status: completed.
02
Drugs
methotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00005945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005945.